The virology records and autopsy reports of all patients ⩾17 years old who underwent an autologous BMT at MDACC between May 1992 and May 1996 were reviewed until 1 year post transplant. The medical ...
From January 2013 to December 2015, 69 patients received an AHSCT in our hospital; 56 patients were included in the study and 13 were excluded because they died before day +100 of causes unrelated to ...
Outcomes of cytomegalovirus pneumonia after hematopoietic cell transplantation have improved modestly over the past 25 years largely due to antiviral treatment and changes in transplantation protocols ...
We studied the efficacy and safety of a risk-adapted approach with ganciclovir to prevent cytomegalovirus (CMV) pneumonia in 41 CMV-seropositive recipients of genotypically human leukocyte ...
Seven marrow transplant recipients were treated with human leukocyte interferon and vidarabine for cytomegalovirus pneumonia. Although the mean virus titer in biopsy and autopsy lung specimens from ...
In a significant advance in improving the safety of donor stem cell transplants, a major clinical trial has shown that a novel agent can protect against the most common viral infection that patients ...
Get a compelling long read and must-have lifestyle tips in your inbox every Sunday morning — great with coffee! Thirty years ago this week, the Centers for Disease Control (CDC) released its ...
A new antiviral drug, Letermovir may protect against cytomegalovirus (CMV) infections which occur after transplantation, finds a research team from the Dana-Farber Cancer Institute and Brigham and ...
CMV is an opportunistic infection that preys on low immunity, and COVID-19 is capable of severe immune suppression, the doctor added. (Representational image) Cytomegalovirus infection is a common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback